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Background: The purpose of this project was to examine the effects of acute garlic supplementation on fibrinolysis
and vasoreactivity both at rest and following maximal exercise.
Methods: Eighteen healthy trained males (20.9 ± 2.2 years, 178 ± 7.7 cm, 75.5 ± 9.6 kg, VO2max = 59.8 ± 6.7
ml • kg−1 • min−1) performed a graded treadmill test to volitional exhaustion. Blood samples were taken at rest,
within two minutes post-exercise, and one hour post-exercise. Eleven of the subjects also had a brachial vasoreactivity
test performed immediately after the blood sample to assess flow-mediated dilation (FMD) of the brachial artery.
Participants were randomly assigned to ingest either 900 mg of powdered garlic or a placebo three hours before
the exercise session. The supplement was distributed in a double-blind, crossover fashion. Participants repeated
the protocol with the other treatment after a 14-day washout period. Paired t-tests were used to compare VO2max
between the two trials. A two-factor (treatment and time) repeated measures analysis of variance (ANOVA) was used to
assess changes in FMD, tPA activity, tPA antigen, and PAI-1 activity. A priori statistical significance was set at P <0.05.
Results: VO2max was greater for the garlic treatment trial vs. placebo (Placebo = 59.8 ± 6.7 ml • kg
−1 • min−1;
Garlic = 61.4 ± 6.6 ml • kg−1 • min−1). There was no main effect for treatment and no treatment x time interaction
for FMD or any fibrinolytic variables examined.
Conclusion: Acute garlic supplementation does not alter vasoreactivity, fibrinolytic potential or the fibrinolytic
response to exercise in young healthy trained males. Acute garlic supplementation does, however, cause a small but
statistically significant increase in VO2max. It remains unclear if this increase in VO2max is of functional importance.Introduction
Prior epidemiological studies have observed that garlic
improves the risk for the development of cardiovascular
disease (CVD) [1, 2]. This positive health outcome is
likely due to many physiological effects. Specifically, gar-
lic can positively affect plasma lipids [3-5], cause reduc-
tions in blood pressure [5-8], and affect changes in
hemostasis [9-16]. Furthermore, some of the blood pres-
sure and hemostatic effects are evident acutely, after a
single dose [7, 9, 12, 13, 16].
The relative risk of myocardial infarction is 5.9 fold
greater in the hour after vigorous exercise [17]. The pur-
ported causes of these exertion-related ischemic events
are thrombosis, coronary vasospasm, or both [18]. Thus,
factors that impact the vascular and/or hemostatic re-
sponses to exercise are clinically significant. Fibrinolysis* Correspondence: womackcx@jmu.edu
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The degree of fibrinolytic potential is influenced in
humans by tissue plasminogen activator (tPA) which
converts plasminogen to plasmin and plasminogen acti-
vator inhibitor 1 (PAI-1), which is the main circulating
inhibitor of tPA. Early studies on garlic supplementation
reported substantial increases in fibrinolytic activity after
acute and chronic supplementation [9-12, 14, 15]. Al-
though the results of these studies are illuminating, the
changes in fibrinolytic activity were assessed globally,
without specific assays for tPA or PAI-1. Thus, the effects
of garlic supplementation on the specific components of
the fibrinolytic system are not known. Furthermore, it is
not known whether garlic affects the fibrinolytic response
to exercise.
There is evidence that garlic elicits vascular benefits
through the enhanced availability of nitric oxide (NO).
Garlic’s influence on NO synthase (eNOS) has been
proposed as a potential mechanism for this enhancedal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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this response [19, 20]. Das et al [21] found that the ac-
tive compounds in garlic can increase eNOS activity
intracellularly, subsequently increasing NO production.
Similar findings by Morihara et al [20] showed that
aged garlic extract (AGE) significantly increased NO
levels in the plasma when compared to baseline values.
Williams et al [22] observed that two weeks of garlic
supplementation significantly increased flow-mediated
dilation in men with coronary artery disease. However,
the effects of acute garlic supplementation on this
measure of vasoreactivity and its effect on the vasor-
eactive response to exercise are unknown. The purpose
of the present study was to evaluate the acute effects of
garlic supplementation on tPA, PAI-1, and flow-
mediated vasodilation, both at rest and in response to
exercise. It was hypothesized that the garlic supplemen-




Eighteen healthy males (age = 20.9 ± 2.2; height = 178.0 ±
7.7 cm; weight = 75.5 ± 9.6 kg) from the James Madison
University community and the surrounding Harrisonburg
area completed this study. The original cohort consisted
of 20 subjects but two of these subjects dropped out. All
participants were trained in that they either: A) partici-
pated in three or more days of vigorous activity for at least
twenty minutes per day or B) participated in seven or
more days of any combination of moderate-intensity or
vigorous-intensity activities achieving a minimum total
physical activity of 3000 MET-min • wk−1. Exclusion cri-
teria included: any known cardiovascular, pulmonary, or
metabolic disease; current tobacco use; current use of any
medication known to influence fibrinolysis; infection;
fever, or illness within two weeks prior to testing; garlic or
flour allergy; and any other medical condition that could
compromise safety. Participants were provided with writ-
ten and verbal information about the experimental proce-
dures, including potential risks, prior to completing an
informed consent form. All procedures were approved
by the James Madison University Committee on Re-
search Involving Human Subjects prior to testing.
Supplementation
Participants were given a packet containing either the
placebo treatment (PT), which consisted of three gel
capsules containing flour, or the garlic treatment (GT),
which consisted of three 300 mg capsules of Kyolic
Brand powdered aged garlic extract (Mission Viejo, CA).
These treatment packets were administered in a double-
blind, cross-over fashion with the order structured to
ensure that an equal number of participants performedthe placebo treatment and the garlic treatment first. Par-
ticipants were instructed to ingest all of the tablets with
a glass of water three hours prior to testing. All tests
were performed before 10 AM to minimize the effect of
diurnal variations on fibrinolysis [23] and each partici-
pant was tested at the same time of day for both trials.
Dietary and exercise controls
Throughout the duration of the study participants were
instructed to: 1) choose a standard “self-selected” meal
to be repeated for the twenty-four hours preceding the
two treatment trials, 2) consume the last meal of the day
no later than twelve hours prior to the treatment trials,
3) avoid consumption of alcohol twenty-four hours prior
to each treatment trial, and 4) avoid exercise immedi-
ately prior to each treatment trial. For the self-selected
meal, all participants completed a 24-hour dietary recall
before the first and second trial. In twelve of the eight-
een participants, at least 75 % of the food items from the
day before the first trial were repeated on the day before
the second trial. For the six participants who did not
meet this criterion, there was no reported garlic inges-
tion the day prior to either trial. Each participant con-
firmed verbally that they did not exercise before the
treatment trials. Participants were allowed to drink water
ad libitum throughout the duration of the study.
Exercise tests
Upon arrival at the laboratory, participants assumed a
semi-recumbent position for 20 min prior to obtaining a
baseline blood sample and measuring flow-mediated
dilation (FMD) of the brachial artery. Participants then
completed a graded exercise test (GXT) to volitional fa-
tigue on a treadmill. Blood sampling and FMD measure-
ments were then obtained immediately after exercise and
again 1 hour after exercise cessation. Participants repeated
the protocol with the other treatment two weeks later.
The GXT was performed on a Stairmaster Clubtrack
612 treadmill (Kirkland, WA). The test began at an initial
speed of 67 m • min−1. Speed was then increased at a rate
of 13.4 m • min−1 each minute until 161 m • min−1 was
reached. At this point, the treadmill speed remained
constant while the elevation increased at a rate of 3.0 % •
min−1 until 15.0 % grade was reached. Speed was then in-
creased once again at a rate of 13 m • min−1 until vol-
itional exhaustion. VO2 was continuously monitored with
a Sensormedics Spectra metabolic cart (Yorba Linda, CA)
and the highest one-minute average was used to deter-
mine VO2max. This protocol has been previously shown
to elicit profound fibrinolytic responses [24, 25].
Blood sampling
For each blood sample, 5 ml of venous blood was col-
lected in a tube treated with acidified citrate (Biopool
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blood was collected in an ethylenediaminetetraacetic
acid (EDTA) tube. Whole blood collected in EDTA was
analyzed for hematocrit using the microhematocrit
method. The remainder of the EDTA sample and the
blood collected in an acidified citrate tube were spun in
a refrigerated centrifuge (Fisher Scientific accuSpin 3r)
operating at 4°C and 10,000 rpm for 20 min to obtain
platelet-poor plasma. Plasma was alliquoted and stored
at -80°C until assayed. Fibrinolytic potential was deter-
mined by assaying for tPA activity, tPA antigen, and
PAI-1 activity. tPA activity was determined by using an
amidolytic activity assay (Biopool International; Ventura,
Calif ). tPA antigen and PAI-1 activity were determined
using an enzyme-linked immunosorbent assay (ELISA)
(American Diagnostica, Greenwich, Conn and Dia-
pharma respectively). All values for tPA and PAI-1 were
corrected for plasma volume changes [26].
Flow mediated dilation
Flow mediated dilation of the brachial artery was mea-
sured on three separate occasions during each trial: at
resting prior to the exercise test, beginning within 2 mi-
nutes post exercise test, and 1 hour post exercise test.
PerformancePlus ECG Diagnostic Electrodes (Vermed:
Bellows Falls, VT) for an electrocardiograph (ECG) were
placed on each participant at the left arm, right arm, and
left hip for the purposes of coordinating blood flow with
cardiac cycles. The distance between the right olecranon
process and the elbow was measured, and a DC-6 Diag-
nostic Ultrasound System (ShenZhen Mindray Bio-
Medical Electronics Co., Ltd.: ShenZhen, China) probe
was placed at approximately 1/3 of this distance from the
elbow to locate the brachial artery. Once the brachial ar-
tery was located and an adequate image achieved, the
ultrasound probe’s position was marked lightly on the
participant’s skin using a permanent marker to allow
for quick relocation of the artery during the trial and
standardization of the measurements. For each FMD
measurement, a DS400 Aneroid Sphygmomanometer
(Hokanson: Bellevue, WA) was placed on the forearm,
distal to the right brachial artery [27]. The cuff was in-
flated to 200 - 250 mmHg (≥25 to 50 mmHg above sys-
tolic arterial pressure) and kept inflated for a period of
five minutes [28]. Blood flow measurements were initi-
ated at least ten seconds prior to cuff release and post
occlusion data collection was continued for ≥ two mi-
nutes [29]. The cuff was removed after completion of
each FMD measurement during the trial.
All data was collected with the use of Microsoft AM
Capture software (Version 8 downloaded from Pennacle
Systems Division of Avid Technologies, Inc. New York)
at a rate of 8 frames per second. Microsoft AM Capture
files were converted using Movavi Video Convertersoftware (Version 10 downloaded from Movavi, Novosibirsk
Province, Russian Federation) and analyzed using Brachial
Analyzer for Research software (Medical Imaging Applica-
tions, LLC. Coralville, IA).
Baseline vessel diameters were recorded as the mean
diameter recorded during the ten seconds prior to cuff
release. This method for measuring baseline diameter
values has been successfully used elsewhere [27, 30-34].
Post-occlusion diameter measurements were recorded
and averaged at four-second intervals (32 frames) during
the first twenty seconds post-occlusion and at five-
second intervals (40 frames) for the remainder of the
two minutes. Peak diameter was recorded as the highest
average diameter measured from among the four- or
five-second intervals during the two minutes of measure-
ment following cuff release [29]. Time to peak diameter
was estimated as the midpoint of the interval in which
peak diameter was recorded. This method for measuring
vessel diameters and computing FMD has been shown to
be equally valid and reliable as QRS-gating brachial artery
diameter measurements [35]. Diameter measurements an-
alyzed with the Brachial Analyzer for Research were
used to calculate FMD, which was calculated as [(peak
diameter – baseline diameter)/baseline diameter] and re-
corded as a percent of change.
Statistical analysis
The primary dependent variables studied for the present
investigation were tPA activity, tPA antigen, PAI-1 activ-
ity, and FMD. A two-factor (treatment and time) re-
peated measures analysis of variance (ANOVA) was
used to assess changes in these variables. Paired t-tests
were used to compare our secondary outcome variable
(VO2max) between the two trials. A priori statistical sig-
nificance was set at P < 0.05. All statistical analysis was
performed using IBM SPSS statistical software.
Results
Gas exchange data was available for seventeen of the
subjects. Fig. 1 displays average relative VO2max for
both conditions, along with the individual data. VO2max
was significantly (p < 0.05) greater with GT [PT = 59.8 ±
6.7 ml • kg−1 • min−1, GT = 61.4 ± 6.6 ml • kg−1 • min−1].
Fibrinolytic potential
One participant was a consistent outlier (greater than
two standard deviations above the mean) for tPA antigen
and PAI-1 activity and was excluded from the analysis of
fibrinolytic variables. A Shapiro-Wilk test demonstrated
that the data was not normally distributed for tPA anti-
gen or PAI-1 activity for at least one time point. These
data were log-transformed prior to ANOVA. Further
analysis revealed that PAI-1 activity was still abnormally


























Fig. 1 Mean values for VO2max for the garlic and placebo conditions.
The individual responses are also displayed as dashed lines. *- Significantly
higher than placebo (P < 0.05)
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ables and normalcy was then achieved for PAI-1.
Figure 2 displays the mean tPA activity and tPA anti-
gen response for the PT and GT. A significant (p < 0.05)
main effect was observed for time as tPA activity in-
creased from pre-exercise [PT = 0.74 ± 0.08 IU • ml−1,
GT = 0.76 ± 0.07 IU • ml−1] to post-exercise [PT = 19.5 ±
2.8 IU • ml−1, GT = 19.8 ± 3.3 IU • ml−1]. Compared to
pre-exercise values, there was no elevation in tPA activ-
ity 1-h post-exercise [PT = 0.69 ± 0.10 IU • ml−1, GT =
0.69 ± 0.06 IU • ml−1]. tPA antigen significantly (p <
0.05) increased from pre-exercise [PT = 3.6 ± 0.46 ng •
ml−1, GT = 4.8 ± 1.0 ng • ml−1] to post-exercise [PT =
15.4 ± 1.8 ng • ml−1, GT = 20.0 ± 3.1 ng • ml−1]. One
hour post-exercise tPA antigen was reduced to baseline
as it was not significantly different than pre-exercise values
[PT = 4.0 ± 0.52 ng • ml−1, GT = 4.8 ± 0.80 ng • ml−1].
There was no main effect for treatment and no treatment x
time interaction for these variables (p > 0.05).
Figure 3 displays the mean PAI-1 activity response for
the PT and GT. A significant (p < 0.05) main effect was
observed for time as PAI-1 activity significantly (p <
0.05) decreased from pre-exercise [PT = 0.63 ± 0.10 ng •
ml−1, GT = 0.92 ± 0.22 ng • ml−1] to post-exercise [PT =
0.16 ± 0.05 ng • ml−1, GT = 0.32 ± 0.13 ng • ml−1]. There
was no difference in pre-exercise PAI-1 activity and PAI-
1 activity 1-h post-exercise [PT = 0.88 ± 0.17 ng • ml−1,GT = 0.97 ± 0.21 ng • ml−1]. There was no significant
main effect (p > 0.05) for treatment or a significant (p >
0.05) treatment x time interaction for PAI-1 activity.
Flow-mediation dilation
Seven of the eighteen participants were excluded from
the analysis of FMD-related variables. Six of the seven
were unable to be analyzed due to poor image quality or
missing data points. A Shapiro-Wilk test revealed that
the remaining 12 data points were abnormally distrib-
uted. This was corrected by removing another partici-
pant that represented an extreme outlier (two data
points were approximately three standard deviations
from the mean). Removal of this participant then re-
sulted in normally distributed data.
Average change in FMD and peak diameter are sum-
marized in Table 1. No significant main effect for treat-
ment (p > 0.05) or time (p > 0.05) or a treatment x time
interaction were found (p > 0.05) for these variables.
Time to peak diameter data is also summarized in
Table 1. No significant main effects for treatment (p >
0.05) or treatment by time interactions were found (p >
0.05). A significant main effect for time (p < 0.05) was
observed as the time to peak diameter was longer imme-
diately after exercise.
Discussion
The primary finding of this study is that acute garlic
supplementation does not improve resting fibrinolytic
potential or vasoreactivity; nor does it affect the fibrino-
lytic or vasoreactive response to exercise in young,
healthy males. Similarly, Legnani and co-workers [16]
did not observe improvements in tPA activity with acute
garlic supplementation. In that investigation, the partici-
pant pool was young and healthy and supplemented with
900 mg of a garlic powder preparation four hours prior
to evaluation. In contrast, several studies have observed
enhancement of the fibrinolytic system within a few
hours after the consumption of garlic. Euglobulin clot
lysis time (ECLT) has been observed to decrease follow-
ing acute administration of garlic oil [9] or raw garlic
[13]. However, in one of these studies, the improved
ECLT from garlic occurred following butter ingestion
[9], while the other study was performed on participants
with heart disease [13]. Thus, the discrepancy of results
could be explained by methodology and population.
It is also possible that the acute garlic supplementation
regimen in the present study could have possibly af-
fected another hemostatic factor, such as fibrinogen or
urinary plasminogen activator, which would also affect
ECLT but does not specifically affect tPA or PAI-1. How-
ever, Kiesewetter et al. [36] did observe significant (56 %
and 51 %, respectively) increases in tPA activity five hours








































Fig. 2 Mean plasma levels of tPA Activity (IU • ml−1) and tPA antigen (ng • ml−1) pre-exercise, post-exercise, and 1-hour post-exercise for the placebo
(white bars) and garlic (gray bars) conditions. *- Significantly higher than pre-exercise (P < 0.05)
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workers [37] measured fibrinolytic potential following
acute garlic supplementation and observed about an 86 %
increase in tPA activity after five hours in a similar subject
sample. It is possible, therefore, that acute garlic supple-
mentation does not impact hemostasis until at least five
hours after ingestion as data reported from our study and
from Legnani et al were four and three hours after supple-
mentation respectively.
In addition to the lack of hemostatic effect in the
present study, acute garlic supplementation also failed to
have an impact on brachial artery vasoreactivity. In prior
studies, garlic improved synthesis of NO in platelets and
tissue preparations [21] as well as production in mice
[19, 20]. Furthermore, chronic AGE supplementation
has been shown to improve brachial vasoreactivity in in-
dividuals with acute hyperhomocysteinemia. Therefore,prior research clearly suggests that garlic is capable of
improving endothelial function and that this improve-
ment can lead to increased vasoreactivity. However, the
fact that the current study was performed on young,
healthy individuals suggests that the effects of an acute
dose in a healthy population are not sufficient to observe
significant changes. Furthermore, it is possible that the
garlic supplementation increased NO synthesis, but not
to the extent that it improved brachial vasoreactivity in
this population. Finally, it is possible that improvements
would have been observed if a sample with cardiovascular
disease, or another condition that compromises vasoreac-
tivity, were studied but this possibility can only be ad-
dressed with future research.
In the present study, we observed a significant increase
in the time to peak diameter immediately following exer-
























Fig. 3 Mean plasma levels of PAI-1 Activity (ng • ml−1) pre-exercise, post-exercise, and 1-hour post-exercise for the placebo (white bars) and garlic
(gray bars) conditions. *- Significantly lower than pre-exercise (P < 0.05)
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trained subjects. This occurred despite the fact that NO
was increased 93 % at 1-hour post-exercise, along with
large arterial diameters at this same time point. It was
suggested that this large arterial diameter, combined
with high levels of circulating NO in the plasma, may
have dilated the vessel to maximal or near maximal
diameter prior to FMD measurement. Thus it is possible
that in this population of young, healthy males, the exer-
cise increased arterial diameter and peak blood flow to a
point that could not be further enhanced by acute garlic
supplementation.
Evidence from Silber et al [39] may also explain why
there was no significant difference (p = 0.524) in peak di-
ameters across all time-points. The current study used
young, healthy, trained males similar in characteristics to
the trained athletes in the study by Rognmo et al [38].
These athletes had larger brachial diameters than the
sedentary controls, and were less prone to increased
dilation due to increased shear stress as their diameters
were already large enough to accommodate increased
blood flow to exercising muscles [38]. As the participantsTable 1 Mean FMD, peak diameter and time to peak diameter (± St
Variable Resting
FMD (mm) Garlic 0.068 ±
Placebo 0.071 ±
Peak diameter (mm) Garlic 4.241 ±
Placebo 4.337 ±
Time to peak diameter (sec) Garlic 56.36 ±
Placebo 51.82 ±in the current study were of similar training status, it is
probable that they too had relatively large brachial artery
diameters. If larger arteries dilate to a lesser extent than
smaller arteries [39], there would be less change in dilation
from resting to peak dilation.
An unexpected secondary finding of the present study is
that acute garlic supplementation causes a slight but sig-
nificant increase in VO2max in young, healthy, trained
males without significantly increasing their treadmill time.
Garlic has been suggested as an anti-fatigue agent, al-
though the specific mechanism of this effect has not been
elucidated [40]. Of the 17 participants whose gas exchange
data was analyzed, thirteen of them achieved a higher
relative VO2max during the garlic trial than during the
placebo trial. The average relative VO2max was 59.8 ml •
kg−1 • min−1 and 61.4 ml • kg−1 • min−1 for the placebo
and garlic trials, respectively. Ince & colleagues [41] ad-
ministered a single dose of garlic to ten college-aged en-
durance athletes and observed a significant increase in
VO2max (57.3 ml • kg
−1 • min−1 for the garlic trial and
55.6 ml • kg−1 • min−1 for the placebo trial) five hours
after garlic ingestion. It was speculated that the observedd. Dev) for both conditions at all three time-points
Post-exercise 1-hour post-exercise
0.032 0.091 ± 0.119 0.084 ± 0.097
0.051 0.071 ± 0.084 0.108 ± 0.097
0.388 4.307 ± 0.383 4.293 ± 0.443
0.516 4.322 ± 0.348 4.463 ± 0.285
19.24 66.36 ± 13.43 60.00 ± 14.66
16.77 69.09 ± 12.81 61.36 ± 13.05
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to improvements in the fluidity of the blood whereby
whole-blood viscosity was decreased due to garlic-induced
reductions in fibrinogen concentration. However, fibrino-
gen was not measured by Ince & colleagues [41] or in the
current study so this possibility cannot be proven. Inter-
estingly, Morihara & coworkers [20] also examined the
impact of aged garlic extract (AGE) on succinate dehydro-
genase (SDH) activity. AGE significantly increased SDH
activity by 40 % in the gastrocnemius muscle of the rats
engaging in repeated endurance exercise on a mechanical
treadmill 5 times per week for 4 weeks as compared to the
control exercising rats which did not receive AGE. This
elevation in SDH activity may indicate AGE enhances aer-
obic metabolism of skeletal muscle during exercise, which
in turn may account for the increase in VO2max observed
in the present study.
The major limitation of the present study is that the
findings are specific to healthy young males with a high
cardiorespiratory endurance. It is entirely possible that
individuals with impaired fibrinolysis and/or diminished
brachial vasoreactivity would experience improvements
in one or both of these parameters with acute garlic sup-
plementation. However, our findings do strongly suggest
that acute garlic supplementation does not impact tPA,
PAI-1 or brachial vasoreactivity in the studied population.
The functional importance of the observed improve-
ments in VO2max is uncertain. The present study found
a 1.6 ml • kg−1 • min−1 increase in VO2max without a
corresponding improvement in treadmill time. Con-
versely, Ince & colleagues [41] observed a 2 ml • kg−1 •
min−1 increase in VO2max as well as a 53.6 s increase in
treadmill time. Both studies used groups of healthy
trained college aged males. Future studies should seek to
replicate the present findings to see if the lack of im-
proved treadmill time persists.
Conclusion
In summation, the present study does not support the
hypothesis that acute supplementation with garlic en-
hances the resting of post-exercise fibrinolysis or vasor-
eactivity in young, healthy males. However it does
appear that acute garlic supplementation does result in a
small but significant increase in VO2max in this popula-
tion. Future studies should evaluate whether these im-
provements in VO2max are of any functional importance.
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